SCHEMBL1102876

SCHEMBL1102876

c1ccc2c(-c3c4ccccc4c(-c4cc5ccccc5c5ccccc45)c4cnccc34)cccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.50
TNF P01375 2/20 0.47
KDM4E B2RXH2 5/20 0.44
HTT P42858 2/20 0.44
POLB P06746 1/20 0.44
RAD52 P43351 1/20 0.44
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
MAPK1 P28482 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
CASP1 P29466 1/20 0.41
HIF1A Q16665 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
IKBKE Q14164 1/20 0.40
TBK1 Q9UHD2 1/20 0.40
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102547 0.92 CYP11B1 (0.57) CYP11B1TNFKDM4EHTTPOLB
SCHEMBL1103685 0.92 CYP11B1 (0.57) CYP11B1TNFKDM4EHTTPOLB
SCHEMBL1103691 0.91 TNF (0.56) TNFKDM4EHTTALDH1A1HPGD
SCHEMBL1102541 0.91 TNF (0.56) TNFKDM4EHTTALDH1A1HPGD
SCHEMBL1102777 0.89 TNF (0.49) CYP11B1TNFKDM4EHTTPOLB
SCHEMBL1102907 0.89 TNF (0.54) TNFKDM4EHTTALDH1A1HPGD
SCHEMBL1102802 0.86 TNF (0.51) TNFKDM4EALDH1A1HPGDMAPK1
SCHEMBL12887215 0.85 TNF (0.40) CYP11B1TNFKDM4EHTTPOLB
SCHEMBL12887355 0.85 CYP11B1 (0.40) CYP11B1TNFKDM4EHTTPOLB
SCHEMBL12886939 0.85 TNF (0.40) CYP11B1TNFKDM4EHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 CYP11B1 836/4885TNF 3803/4885KDM4E 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.